Astrazeneca Pharma India standalone net profit rises 288.60% in the June 2016 quarter

Sales rise 15.05% to Rs 138.09 crore

Net profit of Astrazeneca Pharma India rose 288.60% to Rs 10.57 crore in the quarter ended June 2016 as against Rs 2.72 crore during the previous quarter ended June 2015. Sales rose 15.05% to Rs 138.09 crore in the quarter ended June 2016 as against Rs 120.03 crore during the previous quarter ended June 2015. ParticularsQuarter EndedJun. 2016Jun. 2015% Var.Sales138.09120.03 15 OPM %11.574.41 -PBDT17.547.00 151 PBT13.472.72 395 NP10.572.72 289

Powered by Capital Market - Live News